Next Article in Journal
Treatment of Regional Metastatic Melanoma of Unknown Primary Origin
Next Article in Special Issue
Diet and Pancreatic Cancer Prevention
Previous Article in Journal
Not so Fast: Co-Requirements for Sonic Hedgehog Induced Brain Tumorigenesis
Previous Article in Special Issue
The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression
Article Menu

Export Article

Open AccessReview
Cancers 2015, 7(3), 1499-1542; doi:10.3390/cancers7030850

Molecular Targeted Intervention for Pancreatic Cancer

Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, PC Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
*
Authors to whom correspondence should be addressed.
Academic Editor: Hildegard M. Schuller
Received: 14 May 2015 / Revised: 24 July 2015 / Accepted: 4 August 2015 / Published: 10 August 2015
View Full-Text   |   Download PDF [771 KB, uploaded 10 August 2015]   |  

Abstract

Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is associated with westernized diet, tobacco, alcohol, obesity, chronic pancreatitis, and family history of pancreatic cancer. New targeted agents and the use of various therapeutic combinations have yet to provide adequate treatments for patients with advanced cancer. To design better preventive and/or treatment strategies against PC, knowledge of PC pathogenesis at the molecular level is vital. With the advent of genetically modified animals, significant advances have been made in understanding the molecular biology and pathogenesis of PC. Currently, several clinical trials and preclinical evaluations are underway to investigate novel agents that target signaling defects in PC. An important consideration in evaluating novel drugs is determining whether an agent can reach the target in concentrations effective to treat the disease. Recently, we have reported evidence for chemoprevention of PC. Here, we provide a comprehensive review of current updates on molecularly targeted interventions, as well as dietary, phytochemical, immunoregulatory, and microenvironment-based approaches for the development of novel therapeutic and preventive regimens. Special attention is given to prevention and treatment in preclinical genetically engineered mouse studies and human clinical studies. View Full-Text
Keywords: pancreatic cancer; chemoprevention; chemotherapy; combination treatment; drug development pancreatic cancer; chemoprevention; chemotherapy; combination treatment; drug development
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Mohammed, A.; Janakiram, N.B.; Pant, S.; Rao, C.V. Molecular Targeted Intervention for Pancreatic Cancer. Cancers 2015, 7, 1499-1542.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top